Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • mugiu17
    Junior Member
    • Jun 2011
    • 2

    #1

    WGA in MeDip-Seq

    Hi!

    I am planning to perform MeDip-seq experiments. Based on my samples, I plan to recover very little amount of methylated DNA. Therefore, I was thinking to perform an amplification step on the immunoprecipitated material before adapter ligation and gel size selection. Has anybody experience in some method of amplification that minimizes the introduction of bias in the experiment?

    Thank you very much!

    MGiulia
  • yoon
    Junior Member
    • May 2011
    • 6

    #2
    hello,
    WGA is not really possible after DNA have been fragmented! Also, Medip usually yield ssDNA which is not possible to be ligated with illumina adapters.

    Comment

    • frozenlyse
      Senior Member
      • Sep 2008
      • 135

      #3
      Originally posted by yoon View Post
      hello,
      WGA is not really possible after DNA have been fragmented! Also, Medip usually yield ssDNA which is not possible to be ligated with illumina adapters.
      So I would suggest you ligate on adaptors before the MeDIP - however the TruSeq adaptors you get from Illumina at the moment are methylated themself (apparently) so you need to get hold of/synthesise unmethylated adaptors.

      Comment

      • mugiu17
        Junior Member
        • Jun 2011
        • 2

        #4
        Thanks for your answers!

        I think that you can use WGA after MeDIP...for example look at http://www.nimblegen.com/products/methylation/tutorial/.
        Moreover, I've found this product:


        These methods have been used MeDIP-Chip analysis, but I have not found any example in MeDIP-seq.

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
          by SEQadmin2



          CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

          Despite this, “CRISPR helped turn genome editing from a specialized technique into
          ...
          07-31-2026, 11:01 AM
        • SEQadmin2
          Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
          by SEQadmin2


          Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

          The systematic characterization of the human proteome has
          ...
          07-20-2026, 11:48 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, 08-06-2026, 07:41 AM
        0 responses
        20 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 08-03-2026, 10:13 AM
        0 responses
        33 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-31-2026, 02:55 AM
        0 responses
        43 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-24-2026, 12:17 PM
        0 responses
        26 views
        0 reactions
        Last Post SEQadmin2  
        Working...